Exploring women's preferences for attributes of long-acting reversible contraceptive (LARC) methods: A discrete choice experiment

被引:0
|
作者
Otekunrin, Oluwaseun A. [1 ]
Olasehinde, Lydia O. [1 ]
Oliobi, Chidimma E. [2 ]
Otekunrin, Olutosin A. [3 ]
Osuolale, Kazeem A. [4 ]
机构
[1] Univ Ibadan, Fac Sci, Dept Stat, Stat Design Invest Unit, Ibadan, Nigeria
[2] Univ Kwazulu Natal, Coll Agr, Sch Math Stat & Comp Sci, Dept Stat, Durban, South Africa
[3] Fed Univ Agr Abeokuta FUNAAB, Dept Agr Econ & Farm Management, Abeokuta, Nigeria
[4] Nigerian Inst Med Res, Grant Monitoring & Evaluat Unit, Yaba, Lagos State, Nigeria
关键词
Contraceptives; Long-acting reversible contraceptive (LARC); methods; Women?s preferences; Discrete choice experiment; Mixed logit model; Nigeria; HEALTH-CARE; DESIGNS;
D O I
10.1016/j.sciaf.2022.e01499
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There is low LARC uptake in Nigeria and not much is documented about Nigerian women's preferences for these products and how these preferences affect women's choices. Therefore, the purpose of this study is to provide empirical evidence on the decision-making behavior of Nigerian women regarding LARCs. Three hypothetical LARCs were presented. Informed by results obtained from the review of relevant literature and focus group discussion held with selected family planning services providers, the identified attributes were effect on weight, cost, LARC effectiveness and effect on bleeding patterns, each at three levels. A D-optimal design was used to construct nine choice sets. An additional choice set was included to conduct the test-retest stability test. The choice sets and other sociodemographic questions formed the discrete choice experiment questionnaire. A random sample of 150 eligible women was selected from women who enrolled and attended family planning clinics in public healthcare facilities in Ibadan, Nigeria through a three-stage sampling technique. Mixed logit modeling was used to obtain estimates of the parameters and willingness to pay (WTP) for each attribute was calculated. The test-retest stability result showed that 76.7% of the respondents responded in a consistent and rational manner. The women preferred LARCs that have no effect on their weights compared to LARCs that cause either slight weight loss or gain. Also, they preferred LARCs that offer 1/10 0 0 level of effectiveness in a year. The most preferred attribute level, 'women experience infrequent bleeding', increases WTP by NGN 13,984.584 (USD 33.68) while the least preferred level, 'women experience frequent/prolonged bleeding', has a negative mean WTP (NGN 19,598.378 (-USD 47.20)) indicating dispreference for the level. Furthermore, women derived higher utilities from very cheap LARCs. Evidence-based information on women's preferences regarding LARC usage would help policymakers in the deployment of strate gies that would ensure that preferred LARCs are procured and made readily available to women.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页数:9
相关论文
共 50 条
  • [31] The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States
    Brah, Aaron T.
    Barthold, Douglas
    Hauber, Brett
    Collier, Ann C.
    Ho, Rodney J. Y.
    Marconi, Vincent C.
    Simoni, Jane M.
    Graham, Susan M.
    [J]. AIDS RESEARCH AND THERAPY, 2022, 19 (01)
  • [32] Characteristics of Women in the United States Who Use Long-Acting Reversible Contraceptive Methods
    Kavanaugh, Megan L.
    Jerman, Jenna
    Hubacher, David
    Kost, Kathryn
    Finer, Lawrence B.
    [J]. OBSTETRICS AND GYNECOLOGY, 2011, 117 (06): : 1349 - 1357
  • [33] Factors that contribute to discontinuation of long-acting reversible contraceptive methods
    Sen, M.
    Anderson, B.
    Yu, D.
    Diaz, J.
    [J]. CONTRACEPTION, 2015, 92 (04) : 407 - 407
  • [34] Long-acting reversible contraceptive use among women veterans
    Koenig, A. F.
    Zhao, X.
    Callegari, L. S.
    Mor, M.
    Borrero, S.
    [J]. CONTRACEPTION, 2017, 96 (04) : 267 - 267
  • [35] METHODS OF CONTRACEPTIVE PROVISION AND THE UPTAKE OF LONG-ACTING REVERSIBLE CONTRACEPTION
    Madden, T.
    [J]. CONTRACEPTION, 2016, 94 (04) : 408 - 408
  • [36] The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception
    Secura, Gina M.
    Allsworth, Jenifer E.
    Madden, Tessa
    Mullersman, Jennifer L.
    Peipert, Jeffrey F.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (02) : 115.e1 - 115.e7
  • [37] POSTPARTUM CONTRACEPTION: A LOOK AT POSTPARTUM LONG-ACTING REVERSIBLE CONTRACEPTIVE (LARC) USE AND REPEAT PREGNANCY
    Zarecki, E.
    Wiley, C.
    Becker, D.
    Lin, J.
    [J]. CONTRACEPTION, 2019, 100 (04) : 335 - 335
  • [38] Usage of Long Acting Reversible Contraceptive methods (LARC) in couples attending for vasectomy counselling
    Moses, Sharon
    Oloto, Emeka
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2008, 13 (03): : 243 - 247
  • [39] IMPACT OF THE INTRODUCTION OF NEWER LONG ACTING REVERSIBLE CONTRACEPTIVE (LARC) METHODS ON LARC USE IN A COMMERCIALLY INSURED POPULATION
    Law, A.
    Pilon, D.
    Lynen, R.
    Laliberte, F.
    Gozalo, L.
    Lefebvre, P.
    Duh, M. S.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A309 - A309
  • [40] Impact of the Introduction of Newer Long Acting Reversible Contraceptive (LARC) Methods on LARC Use in a Commercially Insured Population
    Law, Amy
    Pilon, Dominic
    Lynen, Richard
    Laliberte, Francois
    Gozalo, Laurence
    Lefebvre, Patrick
    Duh, Mei S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 655 - 656